The Mantoux test, also known as the tuberculin skin test, is a diagnostic tool used to detect the presence of tuberculosis (TB) infection in individuals. It is named after its inventor, Dr.

Charles Mantoux, a French physician who developed the test in the early 20th century. The Mantoux test is a widely used method to screen for TB infection, especially in countries with a high prevalence of the disease.

How Does the Mantoux Test Work?

The Mantoux test involves injecting a small amount of tuberculin, a purified protein derivative (PPD), into the inner surface of the forearm. Tuberculin is derived from the Mycobacterium tuberculosis bacterium, which causes TB.

The PPD solution stimulates the body’s immune system, specifically T cells, to provoke a response if TB infection is present.

After the tuberculin injection is administered, a small, raised bump will appear at the injection site within 48 to 72 hours in individuals who have been infected with TB bacteria.

The size of the bump is measured in millimeters and is an indicator of the individual’s immune response to the TB infection.

Who Should Get a Mantoux Test?

The Mantoux test is commonly performed on individuals who have had close contact with someone known to have active TB disease. It is also recommended for individuals with certain risk factors, such as:.

• Individuals from regions with a high prevalence of TB
• Healthcare workers
• Individuals with weakened immune systems
• Individuals with HIV/AIDS
• Close contacts of individuals with TB

It is important to note that the Mantoux test is not recommended for individuals who have previously received the Bacille Calmette-Guérin (BCG) vaccine, as it can cause false-positive results.

The BCG vaccine is often given in countries with a high prevalence of TB to protect against severe forms of the disease in children.

The Procedure: How is a Mantoux Test Administered?

The Mantoux test is relatively simple and performed by a healthcare professional. The steps involved in administering the test are as follows:.

Related Article Understanding Mantoux Testing and Its Importance

1. The healthcare professional cleans and sterilizes the inner surface of the forearm using alcohol.
2. A small, defined amount of tuberculin PPD is injected just below the surface of the skin using a small needle.
3. After the injection, the healthcare professional ensures that a small wheal (raised bump) is formed at the injection site.
4. The individual receiving the test must not rub or scratch the injection site to prevent the tuberculin from spreading.
5. After 48 to 72 hours, the individual must visit the healthcare professional again for the evaluation of the test results.
6. The healthcare professional measures the size of the raised bump (induration) using a ruler or caliper.
7. The measurement is recorded in millimeters and provides an indication of the immune response to TB infection.

Interpreting the Mantoux Test Results

The interpretation of the Mantoux test results depends on the size of the induration at the injection site. The following criteria are commonly used to determine the test outcome:.

• 0-4 mm induration: Typically considered negative, indicating a low likelihood of TB infection. However, in immunocompromised individuals, this may be considered positive.
• 5-9 mm induration: This is considered positive in individuals with certain risk factors, such as close contacts of individuals with TB or immunocompromised individuals.
• 10-14 mm induration: Generally considered positive in individuals with risk factors such as recent immigrants from high-prevalence TB regions, healthcare workers, and individuals with comorbidities (e.g., diabetes, chronic renal failure).
• 15 mm or larger induration: Usually considered positive in individuals with no known risk factors for TB.

It is important to consider the individual’s risk factors, clinical symptoms, and other diagnostic tests when interpreting the Mantoux test results.

A positive Mantoux test does not necessarily mean active TB disease is present, but it indicates exposure to TB bacteria and the need for further evaluation.

Advantages and Limitations of the Mantoux Test

The Mantoux test offers several advantages in the diagnosis and screening of TB infection:.

• It is a relatively simple and cost-effective test.
• It provides an indication of exposure to TB bacteria, helping identify individuals who may require further evaluation or treatment.
• It can be performed on individuals of all age groups.

However, the Mantoux test also has certain limitations:.

• It cannot differentiate between latent TB infection and active TB disease.
• It may yield false-negative results, particularly in individuals with weakened immune systems.
• It can produce false-positive results in individuals who have received the BCG vaccine.
• It requires a return visit to the healthcare professional for the evaluation of test results, which may lead to delays in diagnosis or treatment initiation.

Given these limitations, the Mantoux test is often used as an initial screening tool for TB infection, followed by other tests such as chest X-rays, sputum microscopy, or nucleic acid amplification tests for a definitive diagnosis.

Conclusion

The Mantoux test, or tuberculin skin test, is a valuable diagnostic tool used to detect exposure to the Mycobacterium tuberculosis bacterium, the causative agent of TB.

It helps identify individuals with latent TB infection who may benefit from further evaluation or treatment. The test is widely used in countries with a high prevalence of TB and is relatively simple and cost-effective. However, it has limitations, including its inability to differentiate between latent infection and active disease.

Therefore, it is essential to interpret the Mantoux test results in conjunction with the individual’s clinical symptoms, risk factors, and other diagnostic tests to make an accurate diagnosis.